James R. Gruber serves as Executive at Eton Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, James R. Gruber has executed 3 insider transactions totaling $673.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 12, 2025 involved selling 4,542 shares valued at $77.2K.
James R. Gruber currently holds 215,713 shares of Eton Pharmaceuticals, Inc. (ETON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James R. Gruber has been a net seller of ETON stock. They have purchased $0 and sold $673.7K worth of shares.
James R. Gruber's most recent insider trade was on Dec 12, 2025, when they sold 4,542 shares at $16.99 per share.
Get notified when new Form 4 filings are submitted
| $16.02 |
| Discretionary |
| Aug 19, 2025 | ETON | $631.6K | Sale | 39,082 | $16.16 | Discretionary |